Clinical Trial

Cold and NSAID Trial for Prevention of Post-ERCP Pancreatitis

Recruiting
View on ClinicalTrials.gov →
Summary
The standard prophylaxis for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is performed with rectal non-steroidal anti-inflammatory drugs (NSAIDs). A recent Japanese study demonstrated the efficacy of irrigating the periampullary region with ice water, however without the concomitant use of NSAIDs. The proposed study is a randomized, single-center, single-blind clinical trial that aims to compare the efficacy of rectal NSAIDs alone versus NSAIDs associated with ice water in the prevention of PEP.
Trial Details
NCT Number NCT07738094
Lead Sponsor Instituto do Cancer do Estado de São Paulo
Conditions Pancreatitis, Acute
Enrollment 462 participants
Start Date 2026-06-09
Primary Completion 2027-08-31 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30